HOME >> MEDICINE >> NEWS
Leading American, German chemists converge to share research, vision

A group of 70 American and German chemists, age 40 or younger, will meet later this month in Durham, N.H. to share scientific ideas and results in leading areas of chemical research, including biomolecular engineering and bioinspired materials, molecular electronics, nanooptics and frontiers in synthesis.

The German-American Frontiers of Chemistry Symposium to be held August 23-25 at the New England Center in Durham is sponsored by the American Chemical Society, the worlds largest scientific society, and the German Chemical Society (Gesellschaft Deutscher Chemiker). Participants were selected by the symposiums organizing committees.

The symposium, which draws elite chemists from academia and industry in each country, provides a forum for chemists to learn about cutting-edge research in each others countries and in areas beyond their own specialties.

Speakers at the symposium will include: Eli Pearce, Ph.D., ACS president and university research professor at Polytechnic University in Brooklyn, N.Y; Gesellschaft Deutscher Chemiker Secretary General Heindirk tom Dieck, Ph.D.; and George Atkinson, Ph.D., University of Arizona professor and Senior Fellow for Science, Technology and Diplomacy at the U.S. Department of State.

The inaugural Frontiers of Chemistry Symposium was held in 2000 in Munich, Germany.

WHAT:
German-American Frontiers of Chemistry Symposium

WHERE:
New England Center in Durham, N.H

WHEN:
Aug. 23-25, 2002


'"/>

Contact: Tiffany Steele McAvoy
t_mcavoy@acs.org
202-872-6042
American Chemical Society
5-Aug-2002


Page: 1

Related medicine news :

1. Leading researchers in allergic disease to gather for 2005 AAAAI Annual Meeting
2. Leading tobacco manufacturer conceals links to tobacco research facility
3. Leading MRSA experts address emergence of superbug
4. Leading causes of blindness for blacks and whites different
5. Leading cancer doctor calls for new guidelines to control early reporting from clinical trials
6. Leading AIDS experts criticize US-sponsored HIV vaccine trial in Thailand
7. Leading the way in novel anti-cancer research
8. Leading anti-cancer factions strengthen bonds
9. Leading NIH-funded medical schools agree on guidelines that would strenghten conflict of interest policies
10. Biochemical Marker Targets Brain Injury Leading To Movement Problems After Stroke
11. New Model Shows How To Eradicate Worlds Leading Infectious Cause Of Blindness

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... 27, 2017 , ... Osteitis pubis may be commonplace and ... it occurs when the muscles around the pelvis become inflamed. Over time, untreated ... torso, as well as accompanying tenderness and weakness. Without proper intervention, it can ...
(Date:3/27/2017)... ... 2017 , ... EpiGentek , a Farmingdale, NY-based biotech ... methylation “gold rush” with their established portfolio of optimized assay kits that measure ... m6A , RNA methylation has received a new burst in interest as ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still in shock after ... best days I’ve had in a long time,” she said. , She thinks the coming ... money that I never thought I would have to help my students.” , The award ...
(Date:3/27/2017)... Schwerzenbach, Switzerland (PRWEB) , ... March 27, 2017 ... ... the food industry. Conventional sodium testing methods are complicated and require expert user ... presents a new analytical method dedicated to the simplified, yet highly accurate, determination ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year ... be an opportunity for area-residents to celebrate two great years while also familiarizing ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and VANCOUVER, British Columbia, March 27, 2017 /PRNewswire/ ... (the "Company" or "Sophiris"), a clinical late-stage biopharmaceutical ... patients with urological diseases, today reported fourth quarter ... corporate highlights. Key Corporate Highlights: ... Development for Localized Prostate Cancer. During 2016, the ...
(Date:3/27/2017)... , March 27, 2017   Pulmatrix, Inc . (NASDAQ: ... to address serious pulmonary diseases, today announced that it has ... cystic fibrosis and asthma to its Scientific Advisory Board ... Richard B. Moss , MD, former chief of ... the Cystic Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... , March 27, 2017  iCAD (Nasdaq: ICAD), ... solutions and radiation therapy for the early identification ... Tomo Detection received Premarket Approval (PMA) from the ... Detection is a first-of-its-kind, concurrent-read computer aided detection ... the latest innovation available on the PowerLook® Breast ...
Breaking Medicine Technology:
Cached News: